V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10380557 | 10040466 | 1.54 | 80.8 | 03 | 2018-04-16 | 2018-04-23 | Irinotecan + Modified De Gramont | null | N | FLUOROURACIL + IRINOTECAN | 100460373 |
| 10380576 | 10040467 | 1.67 | 41.6 | Palliative (P) | 2019-10-25 | 2019-10-25 | Busulfan Oral | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101694877 |
| 10380662 | 10040469 | 1.57 | 65 | Curative (C) | 2018-07-06 | 2018-07-09 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 101084464 |
| 10380685 | 10040470 | 1.77 | null | Palliative (P) | 2019-03-27 | 2019-04-02 | FEC 60 or 75 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101306133 |
| 10380704 | 10040471 | 1.69 | 58.2 | Neo-adjuvant (N) | 2019-09-15 | 2019-09-23 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101684018 |
| 10380724 | 10040472 | 0 | 68.2 | null | 2022-03-28 | 2022-04-05 | CHOP - 21 days | 99 | null | CLADRIBINE | 101819839 |
| 10380779 | 10040474 | 0 | 78 | Curative (C) | 2021-06-07 | 2021-06-12 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | MITOMYCIN | 101083140 |
| 10380945 | 10040477 | null | 0 | Palliative (P) | 2019-02-03 | 2019-02-09 | Sunitinib | 02 | N | SUNITINIB | 101486301 |
| 10380958 | 10040478 | 1.59 | 94.8 | null | 2019-10-03 | 2019-10-22 | NIVOLUMAB | N | null | NIVOLUMAB | 100038351 |
| 10381031 | 10040479 | 1.67 | 90.4 | Curative (C) | 2016-02-15 | 2016-03-03 | Cytarabine Low Dose | null | N | CISPLATIN + FLUOROURACIL | 100353151 |
| 10381044 | 10040480 | 0 | 0 | Curative (C) | 2018-06-26 | 2019-05-30 | null | 02 | N | MITOMYCIN | 100273237 |
| 10381113 | 10040481 | 1.62 | 49.3 | null | 2018-06-28 | 2018-07-05 | CHOP | null | null | VENETOCLAX | 101216699 |
| 10381159 | 10040484 | 1.68 | 73 | null | 2017-03-13 | 2017-03-14 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 101151959 |
| 10381245 | 10040487 | 1.66 | 82 | Palliative (P) | 2020-02-08 | 2020-02-12 | R GCVP | 02 | null | CYTARABINE | 100594412 |
| 10381266 | 10040488 | 1.77 | 69 | Curative (C) | 2019-05-14 | 2019-05-28 | Cyclophosphamide + Docetaxel | 02 | N | BCG | 100482168 |
| 10381277 | 10040489 | 1.78 | 72.1 | 03 | 2017-10-28 | 2019-12-31 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101543554 |
| 10381334 | 10040492 | null | 84.3 | 03 | 2019-03-01 | 2019-03-06 | CHOP R | N | N | CHOP R | 101588226 |
| 10381468 | 10040496 | 1.69 | null | null | 2019-01-08 | 2019-02-02 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101007396 |
| 10381500 | 10040497 | 1.57 | 74.9 | null | 2018-12-12 | 2021-07-31 | Palbociclib | 02 | null | PALBOCICLIB | 101359281 |
| 10381596 | 10040498 | 1.56 | 41.6 | Palliative (P) | null | null | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 101536380 |
| 10381607 | 10040499 | 1.82 | 78 | 03 | 2016-11-27 | 2016-12-15 | Venetoclax | 02 | N | POMALIDOMIDE | 100997509 |
| 10381617 | 10040500 | 1.74 | 66.5 | 03 | 2019-07-05 | 2019-08-12 | Palbociclib | 02 | N | PALBOCICLIB | 101270869 |
| 10381694 | 10040503 | 0 | null | Palliative (P) | 2018-11-22 | 2018-11-22 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | null | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100114124 |
| 10381752 | 10040504 | 1.72 | 10 | null | 2018-04-12 | 2018-04-16 | R Chlorambucil | null | null | CHLORAMBUCIL + RITUXIMAB | 100779953 |
| 10381767 | 10040505 | 1.55 | 86.5 | Curative (C) | 2017-10-04 | 2017-10-06 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | BCG | 101321176 |
| 10381804 | 10040506 | 1.54 | 90 | Adjuvant (A) | 2020-10-30 | 2020-11-04 | CTD Attenuated (Thalidomide 100mg) | N | N | CAPECITABINE + CISPLATIN | 101699551 |
| 10381819 | 10040507 | 1.66 | 91 | Curative (C) | 2018-02-27 | 2018-03-11 | FEC + DOCETAXEL | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100626227 |
| 10381826 | 10040508 | 1.68 | 62 | 03 | 2022-01-04 | 2022-01-12 | Avelumab | 2 | N | AVELUMAB | 101598581 |
| 10382031 | 10040509 | 1.6 | 94 | null | 2019-11-04 | 2019-11-09 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101623011 |
| 10382040 | 10040510 | null | 62 | null | 2017-04-16 | 2017-04-16 | null | N | N | MITOMYCIN | 100760887 |
| 10382128 | 10040511 | null | 0 | Palliative (P) | 2018-09-13 | 2018-09-14 | Temozolomide 200mg/m2 | 02 | null | TEMOZOLOMIDE | 100329831 |
| 10382141 | 10040512 | 1.78 | 100 | 03 | 2017-05-15 | 2017-05-15 | Venetoclax | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100206255 |
| 10382142 | 10040513 | 1.57 | 79 | Palliative (P) | 2019-04-26 | 2019-05-07 | Cladribine (subcut) 5 days | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100432643 |
| 10382195 | 10040514 | null | null | Palliative (P) | 2017-08-07 | 2017-08-29 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100000550 |
| 10382333 | 10040516 | 1.52 | 54.75 | 03 | 2010-09-22 | 2016-01-15 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 100789049 |
| 10382335 | 10040517 | 1.66 | 78 | Palliative (P) | 2019-06-12 | 2019-06-16 | FEC 60 or 75 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101566184 |
| 10382392 | 10040518 | 1.77 | 73 | Palliative (P) | 2019-06-20 | 2019-06-29 | Cladribine (subcut) 5 days | 01 | N | MITOMYCIN | 101233529 |
| 10382416 | 10040519 | null | null | Curative (C) | 2017-03-28 | 2017-03-29 | FEC 60 or 75 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100292915 |
| 10382456 | 10040521 | 1.6 | 0 | Adjuvant (A) | 2019-05-02 | 2019-05-05 | Bortezomib +/- Dexamethasone | N | N | BORTEZOMIB | 101519816 |
| 10382501 | 10040522 | 1.59 | 77.5 | Curative (C) | null | 2020-01-22 | Capecitabine + Cisplatin | 02 | Y | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100185868 |
| 10382510 | 10040523 | 1.72 | 85.3 | Adjuvant (A) | 2017-02-18 | 2017-03-11 | null | 02 | N | CAPECITABINE + GEMCITABINE | 101256055 |
| 10382697 | 10040527 | 1.69 | 57.2 | Palliative (P) | 2020-07-19 | 2020-08-14 | IPILIMUMAB + NIVOLUMAB | null | N | IPILIMUMAB + NIVOLUMAB | 100137373 |
| 10382719 | 10040528 | 1.57 | 94 | null | 2019-04-27 | 2019-05-06 | FEC 60 or 75 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101139388 |
| 10382725 | 10040529 | 1.63 | 88.9 | Adjuvant (A) | 2019-10-30 | 2019-11-10 | CISPLATIN + FLUOROURACIL | N | N | CVP R | 101194759 |
| 10382751 | 10040531 | 1.85 | 0 | Adjuvant (A) | null | 2018-10-19 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100074279 |
| 10382854 | 10040532 | 1.67 | 94.6 | Palliative (P) | 2017-01-04 | 2020-10-28 | CHOP R - 21 days | 02 | N | CHOP R | 100431830 |
| 10382874 | 10040533 | 0 | 0 | Adjuvant (A) | 2019-08-18 | 2019-08-18 | Busulfan Oral | 02 | N | PAZOPANIB | 100366939 |
| 10382899 | 10040534 | 1.68 | 77.9 | null | null | 2019-10-29 | BUSULFAN | 02 | N | CLADRIBINE | 101706295 |
| 10382905 | 10040535 | 1.72 | 55.4 | null | 2019-02-26 | 2019-02-26 | R Chlorambucil | 02 | null | CHLORAMBUCIL + RITUXIMAB | 101547792 |
| 10382941 | 10040536 | 1.62 | 48.6 | Palliative (P) | 2018-12-11 | 2018-12-18 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100631479 |